McMillan Shakespeare Ltd (ASX: MMS) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

McMillan Shakespeare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.18 billion
P/E Ratio 12.43
Dividend Yield 8.70%
Shares Outstanding 69.64 million
Earnings per share 1.368
Dividend per share 1.54
Year To Date Return -0.23%
Earnings Yield 8.04%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • McMillan Shakespeare Ltd (ASX: MMS)
    Latest News

    a woman
    Share Fallers

    Why the Eclipx share price is crashing lower again today

    The Eclipx Group Ltd (ASX:ECX) share price has crashed lower again on Wednesday. Here's what sent its shares lower this…

    Read more »

    a woman
    Share Gainers

    Why the Eclipx share price surged 16% on the ASX yesterday

    The Eclipx Group Ltd (ASX: ECX) share price surged 16% higher yesterday to recover some of its heavy losses recorded…

    Read more »

    a woman
    Share Fallers

    These were the worst performing shares on the ASX 200 last week

    The Eclipx Group Ltd (ASX:ECX) share price was one of the worst performers on the ASX 200 last week...

    Read more »

    a woman
    Share Gainers

    Eclipx share price rockets 21% on early ASX market update

    The Eclipx Group Ltd (ASX: ECX) share price has retraced some of its heavy losses over the last week as…

    Read more »

    a woman
    Share Fallers

    Eclipx share price plummeted 12% on Tuesday as nightmare week on the ASX continues

    The Eclipx Group Ltd (ASX: ECX) share price crashed another 12% lower yesterday as the group struggles to stop the…

    Read more »

    a woman
    Share Fallers

    Why the Eclipx share price continues to plummet lower on the ASX this week

    The Eclipx Group Ltd (ASX: ECX) share price continued to crash lower on the ASX yesterday as it fell a…

    Read more »

    a woman
    Share Market News

    5 things to watch on the ASX 200 on Friday

    Atlas Arteria Group (ASX:ALX), Oil Search Limited (ASX:OSH), and St Barbara Ltd (ASX:SBM) shares will be on watch on Friday.…

    Read more »

    a woman
    ⏸️ Investing

    The Eclipx share price is lower again after crashing 56% on the ASX yesterday

    The Eclipx Group Limited (ASX: ECX) saw more than half of its value wiped in just one day as the…

    Read more »

    a woman
    Share Gainers

    ALL ORDINARIES finishes lower Wednesday: 8 shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished lower on Wednesday.

    Read more »

    a woman
    Share Market News

    S&P/ ASX 200 member Eclipx just saw its share price fall 56% in a day

    The Eclipx Group Ltd (ASX:ECX) share price fell after McMillan Shakespeare Limited (ASX:MMS) halted its takeover offer.

    Read more »

    a woman
    ⏸️ Investing

    Why the McMillan Shakespeare share price soared as Eclipx's share price tanked

    McMillan Shakespeare Limited (ASX: MMS) share price has risen 3.50% after a trading update by Eclipx Group Limited (ASX: ECX)…

    Read more »

    a woman
    Mergers & Acquisitions

    Eclipx share price freefalls 55% after trading conditions deteriorate

    The Eclipx Group Limited (ASX: ECX) share price has plummeted 55% lower as the company's market update cited weak trading…

    Read more »

    Frequently Asked Questions

    Yes, McMillan Shakespeare historically pays two fully franked dividends a year.

    McMillan Shakespeare generally pays its shareholder dividends in March and September.

    McMillan Shakespeare Ltd was listed on the ASX on 15 March 2004.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    11 Sep 2025 $0.7700 100.00% Final 26 Sep 2025
    13 Mar 2025 $0.7100 100.00% Interim 28 Mar 2025
    12 Sep 2024 $0.7800 100.00% Final 27 Sep 2024
    07 Mar 2024 $0.7600 100.00% Interim 22 Mar 2024
    07 Sep 2023 $0.6600 100.00% Final 22 Sep 2023
    09 Mar 2023 $0.5800 100.00% Final 24 Mar 2023
    26 Oct 2022 $0.7400 100.00% Final 10 Nov 2022
    10 Mar 2022 $0.3400 100.00% Interim 25 Mar 2022
    09 Sep 2021 $0.3110 100.00% Final 24 Sep 2021
    11 Mar 2021 $0.3020 100.00% Interim 26 Mar 2021
    05 Mar 2020 $0.3400 100.00% Interim 20 Mar 2020
    28 Aug 2019 $0.4000 100.00% Final 11 Sep 2019
    07 Mar 2019 $0.3400 100.00% Interim 22 Mar 2019
    13 Sep 2018 $0.4000 100.00% Final 28 Sep 2018
    15 Mar 2018 $0.3300 100.00% Interim 29 Mar 2018
    28 Sep 2017 $0.0000 100.00% Final 13 Oct 2017
    30 Mar 2017 $0.3100 100.00% Interim 13 Apr 2017
    29 Sep 2016 $0.3400 100.00% Final 14 Oct 2016
    31 Mar 2016 $0.2900 100.00% Interim 15 Apr 2016
    16 Sep 2010 $0.1400 100.00% Final 15 Oct 2010
    08 Mar 2006 $0.0250 100.00% Interim 29 Mar 2006
    18 Aug 2005 $0.0240 100.00% Final 16 Sep 2005

    MMS ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About McMillan Shakespeare Ltd

    McMillan Shakespeare Ltd (ASX: MMS) is an employee benefits provider. Its services include salary packaging, novated leasing, disability plan management and support coordination, asset management, and related financial products and services.

    The company's asset management businesses provide motor vehicle leasing and fleet management services, as well as fleet and consumer financing.

    McMillan Shakespeare consists of more than 20 subsidiaries, the majority incorporated in Australia but also in New Zealand and the United Kingdom.

    MMS Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    05 Feb 2026 $16.93 $-0.08 -0.47% 294,976 $17.00 $17.05 $16.68
    04 Feb 2026 $17.01 $-0.32 -1.85% 191,952 $17.33 $17.33 $16.98
    03 Feb 2026 $17.33 $0.08 0.46% 92,921 $17.50 $17.50 $17.23
    02 Feb 2026 $17.25 $0.20 1.17% 100,982 $17.05 $17.48 $17.05
    30 Jan 2026 $17.05 $-0.11 -0.64% 337,178 $17.02 $17.25 $16.97
    29 Jan 2026 $17.16 $-0.11 -0.64% 142,160 $17.30 $17.36 $17.01
    28 Jan 2026 $17.27 $-0.02 -0.12% 273,288 $17.30 $17.44 $17.20
    27 Jan 2026 $17.29 $-0.02 -0.12% 142,299 $17.32 $17.52 $17.13
    23 Jan 2026 $17.31 $0.31 1.82% 109,494 $17.16 $17.44 $17.16
    22 Jan 2026 $17.00 $-0.12 -0.70% 332,346 $17.12 $17.41 $17.00
    21 Jan 2026 $17.12 $-0.16 -0.93% 240,685 $17.22 $17.22 $16.85
    20 Jan 2026 $17.28 $-0.04 -0.23% 127,542 $17.31 $17.36 $17.10
    19 Jan 2026 $17.32 $0.07 0.41% 152,381 $17.39 $17.51 $17.20
    16 Jan 2026 $17.25 $0.12 0.70% 60,819 $17.14 $17.29 $17.07
    15 Jan 2026 $17.13 $0.00 0.00% 84,785 $17.13 $17.44 $17.04
    14 Jan 2026 $17.13 $-0.36 -2.06% 157,208 $17.49 $17.49 $17.13
    13 Jan 2026 $17.49 $0.00 0.00% 109,154 $17.70 $17.70 $17.46
    12 Jan 2026 $17.49 $0.03 0.17% 103,798 $17.51 $17.80 $17.40
    09 Jan 2026 $17.46 $0.12 0.69% 81,429 $17.40 $17.59 $17.38
    08 Jan 2026 $17.34 $0.13 0.76% 68,884 $17.24 $17.34 $17.12
    07 Jan 2026 $17.21 $0.11 0.64% 89,773 $17.15 $17.34 $17.05

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Dec 2025 Robert (Rob) De Luca Issued 55,123 $951,422
    Director remuneration. 1,51,977 Rights
    16 Sep 2025 Robert (Rob) De Luca Issued 91,232 $1,560,979
    Conversion of securities.
    16 Sep 2025 Robert (Rob) De Luca Transfer 8,668 $148,309
    Off-market transfer. Assuming off market transfer of shares
    16 Sep 2025 Robert (Rob) De Luca Expiry 2,729 $46,693
    As advised by the company. Expired
    16 Sep 2025 Robert (Rob) De Luca Exercise 91,232 $1,560,979
    Conversion of securities. 99,583 Rights
    16 Sep 2025 Robert (Rob) De Luca Transfer 8,668 $148,309
    Off-market transfer. Assuming off market transfer of shares
    12 Sep 2025 Robert (Rob) De Luca Issued 5,884 $104,441
    Director remuneration. 1,90,815 Rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Bruce John Akhurst Non-Executive Director Apr 2021
    Mr Akhurst is currently the Chair of the Peter McCallum Cancer Foundation. He was previously the Chairman and Director of Tabcorp Holdings Limited, CEO of Sensis, Group MD and General Counsel of Telstra, Partner of Mallesons Stephen Jaques, Council Member of RMIT University and a Director of Vocus Group Limited. He is a member of Member of Risk and Compliance Committee.
    Mr John G Bennetts Non-Executive Director Dec 2003
    Mr Bennetts is an experienced investor and has been the founder and director of several successful Australian companies. He owns businesses in varied industries including technology and finance. He is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also provided corporate advisory services to a range of companies in Australia and Asia.
    Mr Ross Chessari Non-Executive Director Dec 2003
    Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, he was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
    Ms Helen Kurincic Non-Executive DirectorNon-Executive Chairman Sep 2018
    Ms Kurincic is a Non-Executive Director of Ramsay Health Care Limited and Carlton Football Club Limited. She has formerly held Board roles across the publicly listed, private, not-for profit and government sectors including Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, insurer HBF Health Limited, Domain Principal Group, DCA Group and Melbourne Health. She is a member of Member of Risk and Compliance Committee and People and Culture Committee.
    Ms Arlene May Tansey Non-Executive Director Nov 2022
    Ms Tansey is a Non-Executive Director of Aristocrat Leisure Limited and La Trobe Financial (including La Trobe Private Credit Fund). She is also a Board member of the Australian National Maritime Museum and University of Wollongong Global Enterprises. She is a former Nonexecutive Director of TPG Telecom, Lendlease Investment Management, WiseTech Global Limited, Infrastructure NSW and the Australian Institute of Company Directors (NSW Division Council). She is Member of the Risk and Compliance Committee and Member of the People Culture Committee.
    Mr Robert (Rob) De Luca Chief Executive OfficerManaging Director May 2022
    Mr De Luca joined MMS in May 2022 and has over 20 years' experience in the Financial Services, Wealth Management, Disability and Healthcare sectors, including roles as Managing Director of Bankwest, and CEO of the National Disability Insurance Agency (NDIA). Prior to joining MMS, he was CEO of Zenitas Healthcare.
    Ms Kathryn Maree Parsons Non-Executive Director May 2020
    Ms Parsons is currently a Non-Executive Director of Nick Scali Limited and Shape Australia Corporation Limited. She has knowledge of accounting, finance, governance and risk management. Formerly an audit partner at Ernst & Young she worked in the firm's US, UK and Australian practices. In addition to her audit client responsibilities, she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. She is Chair of the Risk and Compliance Committee and Member of the People and Culture Committee.
    Ms Michelle Siekierka General CounselCompany Secretary Oct 2025
    -
    Michelle Siekierka General CounselCompany Secretary
    -
    Mr P. Varro Group Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Aust) Ltd 16,009,568 22.99%
    Citicorp Nominees Pty Limited 7,245,450 10.40%
    Chessari Holdings Pty Ltd 6,050,941 8.69%
    J P Morgan Nominees Australia Pty Limited 5,611,150 8.06%
    Asia Pac Technology Pty Ltd 3,068,025 4.41%
    Ubs Nominees Pty Ltd 1,377,875 1.98%
    Ann Leslie Ryan 1,008,418 1.45%
    BNP Paribas Norns Pty Ltd 569,534 0.82%
    Mohl Invest Pty Ltd <Mohl Super Fund A/C> 560,000 0.80%
    Warbont Nominees Pty Ltd cUnpaid Entrepot A/C> 476,686 0.68%
    National Nominees Limited 423,892 0.61%
    HSBC Custody Nominees (Australia) Limited 362,176 0.52%
    Tarrina Holdings Pty Ltd cTarrina Holding S/F A/C> 349,777 0.50%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 294,721 0.42%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 216,352 0.31%
    Mestjo Pty Ltd 214,790 0.31%
    Mod Enterprises Pty Ltd 193,139 0.28%
    Birdseye No2 Management Pty Ltd <Birdseye Super No2 Fund A/C> 160,000 0.23%
    Isnf (Kn) Investments Pty Ltd clsnf Investments A/C> 155,983 0.22%
    Tn Terrigal Pty Ltd <Tn Terrigal A/C> 155,983 0.22%

    Profile

    since

    Note